These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31165762)

  • 1. Cytoplasmic sequestration of the RhoA effector mDiaphanous1 by Prohibitin2 promotes muscle differentiation.
    Saleh A; Subramaniam G; Raychaudhuri S; Dhawan J
    Sci Rep; 2019 Jun; 9(1):8302. PubMed ID: 31165762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA.
    Héron-Milhavet L; Mamaeva D; Rochat A; Lamb NJ; Fernandez A
    J Cell Physiol; 2008 Jan; 214(1):158-65. PubMed ID: 17565718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RhoA effector mDiaphanous regulates MyoD expression and cell cycle progression via SRF-dependent and SRF-independent pathways.
    Gopinath SD; Narumiya S; Dhawan J
    J Cell Sci; 2007 Sep; 120(Pt 17):3086-98. PubMed ID: 17684061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.
    Sun L; Liu L; Yang XJ; Wu Z
    J Cell Sci; 2004 Jun; 117(Pt 14):3021-9. PubMed ID: 15173318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
    Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
    Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anchorage-dependent control of muscle-specific gene expression in C2C12 mouse myoblasts.
    Milasincic DJ; Dhawan J; Farmer SR
    In Vitro Cell Dev Biol Anim; 1996 Feb; 32(2):90-9. PubMed ID: 8907122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stau1 negatively regulates myogenic differentiation in C2C12 cells.
    Yamaguchi Y; Oohinata R; Naiki T; Irie K
    Genes Cells; 2008 Jun; 13(6):583-92. PubMed ID: 18422603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine regulation of RhoA and Rock is required for skeletal muscle differentiation.
    Castellani L; Salvati E; Alemà S; Falcone G
    J Biol Chem; 2006 Jun; 281(22):15249-57. PubMed ID: 16574652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts.
    Carnac G; Primig M; Kitzmann M; Chafey P; Tuil D; Lamb N; Fernandez A
    Mol Biol Cell; 1998 Jul; 9(7):1891-902. PubMed ID: 9658178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
    Downes M; Carozzi AJ; Muscat GE
    Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tip60 regulates myoblast differentiation by enhancing the transcriptional activity of MyoD via their physical interactions.
    Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
    FEBS J; 2011 Nov; 278(22):4394-404. PubMed ID: 21936881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of decreased O-GlcNAc glycosylation of Mef2D for its recruitment to the myogenin promoter.
    Ogawa M; Sakakibara Y; Kamemura K
    Biochem Biophys Res Commun; 2013 Apr; 433(4):558-62. PubMed ID: 23523791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hitachi K; Nakatani M; Takasaki A; Ouchi Y; Uezumi A; Ageta H; Inagaki H; Kurahashi H; Tsuchida K
    EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30622218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions of proliferation and differentiation signaling pathways in myogenesis].
    Milewska M; Grabiec K; Grzelkowska-Kowalczyk K
    Postepy Hig Med Dosw (Online); 2014 May; 68():516-26. PubMed ID: 24864103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Di-(2-ethylhexyl)-phthalate reduces MyoD and myogenin expression and inhibits myogenic differentiation in C2C12 cells.
    Chen SS; Hung HT; Chen TJ; Hung HS; Wang DC
    J Toxicol Sci; 2013; 38(5):783-91. PubMed ID: 24067726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2B1 modulates chromatin state and MyoD occupancy to enhance expressions of myogenic genes.
    Chen KW; Chang YJ; Yeh CM; Lian YL; Chan MW; Kao CF; Chen L
    Biochim Biophys Acta Gene Regul Mech; 2017 Feb; 1860(2):270-281. PubMed ID: 28039048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription of MyoD and myogenin in the non-contractile electrogenic cells of the weakly electric fish, Sternopygus macrurus.
    Kim JA; Jonsson CB; Calderone T; Unguez GA
    Dev Genes Evol; 2004 Aug; 214(8):380-92. PubMed ID: 15309633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUNC, a long noncoding RNA that facilitates the function of MyoD in skeletal myogenesis.
    Mueller AC; Cichewicz MA; Dey BK; Layer R; Reon BJ; Gagan JR; Dutta A
    Mol Cell Biol; 2015 Feb; 35(3):498-513. PubMed ID: 25403490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.